Formulation of wedelolactone enriched extract with enhanced potential to inhibit cytokines in experimental arthritis

Atre B N (1) , Arulmozhi S (2) , Sathiyanarayanan L (3) , Dhapte-Pawar V V (4) , Mahadik K R (5)
(1) Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra-411038, India, India ,
(2) Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra-411038, India, India ,
(3) Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra-411038, India, India ,
(4) Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra-411038, India, India ,
(5) Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra-411038, India, India

Abstract

Eclipta alba Linn. (Asteraceae) is traditionally claimed and reported to possess antarthritic and anti-inflammatory activity. Wedelolactone, an active constituent of Eclipta alba Linn responsible for its therapeutic effectiveness, is poorly water soluble and less bioavailable. Hence in the present study, we proposed a SNEDDS formulation of wedelolactone rich extracts of Eclipta alba Linn. (EAF) and evaluated its effect in Freund's complete adjuvant (FCA) induced arthritis in rats. EAF reduced increase in paw volume and hyperalgesia in 50, 100 and 200 mg/kg doses significantly. It restored all cytokines (Tumor Necrosis Factor-α, Interleukin-1β and Interleukin-6); hematological and biochemical parameters altered due to FCA induction. The histopathology further supported the potential of EAF in arresting the progress of the disease. It protected cartilage destruction and exudation of inflammatory cells dose dependently. In conclusion, the EAF exhibited potent antarthritic potential due to the increased bioavailability of wedelolactone and other constituents. The mechanism of action is mainly mediated through inhibition of cytokines, anti-inflammatory and antioxidant potential of wedelolactone.

Full text article

Generated from XML file

References

Atre, B. N., Arulmozhi, S., Sathiynarayanan, L., Dhapte, V. V., Mahadik, K. R. 2020. Disease modifying potential of wedelolactone rich fraction of Eclipta alba Linn in adjuvant induced arthritis in rats by inhibition of proinflammatory cytokines. International Journal of Pharmaceutical Sciences and Research, 11(12):6067–6077.

Cai, X., Wong, Y. F., Zhou, H., Xie, Y., Liu, Z. Q., Jiang, Z. H., Bian, Z.X., Xu, H.X., Liu, L. 2006. The comparative study of Sprague– Dawley and Lewis rats in adjuvant-induced arthritis. Naunyn-Schmiedeberg’s Archives of Pharmacology, 373(2):140–147.

Chung, I.-M., Rajakumar, G., Lee, J.-H., Kim, S.- H., Thiruvengadam, M. 2017. Ethnopharmacological uses, phytochemistry, biological activities, and biotechnological applications of Eclipta prostrata. Applied Microbiology and Biotechnology, 101(13):5247–5257.

Ebel, A. V., Dell, J. R. O. 2021. Clinical Features, Diagnosis, and Treatment of Rheumatoid Arthritis. Physician Assistant Clinics, 6(1):41–60.

Jalalpure, S. S., Mandavkar, Y. D., Khalure, P. R., Shinde, G. S., Shelar, P. A., Shah, A. S. 2011. Antiarthritic activity of various extracts of Mesua ferrea Linn. seed. Journal of Ethnopharmacology, 138(3):700–704.

Jiang, C., He, X., Yang, X., Zhang, S., Li, H., Song, Z. 2014. Phytomedicine Anti-rheumatoid arthritic activity of flavonoids from Daphne genkwa. European Journal of Integrative Medicine, 21(6):830– 837.

Kobori,M., Yang,Z., Gong,D., Heissmeyer,V., Zhu H. 2004. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex. Cell Death and Differentiation, 11(1):123–130.

Liu, X. Y., Xu, L., Wang, Y., Li, J. X., Zhang, Y., Zhang, C., Wang, S. S., Zhang, X. M. 2017. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. International Immunopharmacology, 44:105–114.

Mahdi, H. J., Khan, N. A. K., Asmawi, M. Z. B., Mahmud, R., Murugaiyah, V. A. 2018. In vivo anti- arthritic and anti-nociceptive effects of ethanol extract of Moringa oleifera leaves on complete Freund’s adjuvant (CFA)-induced arthritis in rats. Integrative Medicine Research, 7(1):85–94.

Mbiantcha, M., Almas, J., Shabana, S.U., Nida, D., Aisha, F. 2017. Anti-arthritic property of crude extracts of Piptadeniastrum africanum (Mimosaceae) in complete Freund’s adjuvant-induced arthritis in rats. BMC Complementary and Alternative Medicine, 17(1):1–16.

Mythilypriya, R., Shanthi, P., Sachdanandam, P. 2008. Salubrious effect of Kalpaamruthaa, a modified indigenous preparation in adjuvant-induced arthritis in rats—A biochemical approach. Chemico-Biological Interactions, 173(2):148–158.

Nagakura, Y., Okada, M., Kohara, A., Kiso, T., Toya, T., Iwai, A., Wanibuchi, F., Yamaguchi, T. 2003. Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics. Journal of Pharmacology and Experimental Therapeutics, 306(2):490–497.

Rao et al. 2020. Anti-arthritic evaluation of Eclipta alba in a murine model Freund’s adjuvant provoked arthritis. International Journal of Research in Pharmaceutical Sciences, 11(2):1902–1907.

Tewtrakul, S., Subhadhirasakul, S., Tansakul, P., Cheenpracha, S., Karalai, C. 2011. Anti-inflammatory Constituents from Eclipta prostrata using RAW264.7 Macrophage Cells. Phytotherapy Research, 25(9):1313–1316.

Umar, S., Umar, K., Sarwar, A. H. M. G., Khan, A., Ahmad, N., Ahmad, S., Katiyar, C. K., Husain, S. A., Khan, H. A. 2014. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine, 21(6):847–856.

Unnikrishn, K. P., Fathima, A., Hashim, K. M., Balachandr, I. 2007. Antioxidant Studies and Determination of Wedelolactone in Eclipta alba. Journal of Plant Sciences, 2(4):459–464.

Upadhyay, K., Gupta, N. K., Dixit, V. K. 2012. Development and characterization of phyto-vesicles of wedelolactone for hepatoprotective activity. Drug Development and Industrial Pharmacy, 38(9):1152–1158.

Yang, M., Feng, X., Ding, J., F, C., X, C. 2017. Nanotherapeutics relieve rheumatoid arthritis. Journal of Controlled Release, 252:108–124.

Zago, B. A., Priyadharshini, A., Vijayakumar, T. M. 2020. Osteoarthritis and Cartilage Open Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review. Osteoarthritis and Cartilage Open, 2(4):100116.

Zhao, Y., Wang, C., Chowahl, Renk, Gong, T., Zhang, Z., Zheng, Y. 2010. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. International Journal of Pharmaceutics, 383(1- 2):170–177.

Authors

Atre B N
Arulmozhi S
pharmarul@gmail.com (Primary Contact)
Sathiyanarayanan L
Dhapte-Pawar V V
Mahadik K R
Atre B N, Arulmozhi S, Sathiyanarayanan L, Dhapte-Pawar V V, & Mahadik K R. (2021). Formulation of wedelolactone enriched extract with enhanced potential to inhibit cytokines in experimental arthritis. International Journal of Research in Pharmaceutical Sciences, 12(2), 1283–1291. Retrieved from https://ijrps.com/home/article/view/165

Article Details

No Related Submission Found